Patent Assignment
Reel/Frame 012122/0623
Assignment of Assignor's Interest
Recorded: 2001-08-27
Pages: 3
Assignee
BIOCRYST PHARMACEUTICALS, INC.
2190 PARKWAY LAKE DRIVE, BIRMINGHAM, ALABAMA, 35244
Covered Property
(1)
Deazaguanine Analog, Preparation Thereof and Use Thereof
Patent:
6,458,799 →
Application:
09/847,998 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 26, 2016
From: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039858/0967 →
Release of Security Interest
Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
Security Interest
Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
Release of Security Interest
Apr 6, 2023
From: MIDCAP FINANCIAL TRUST
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 063348/0762 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →